1, 2). 1␣,25(OH) 2 D 3 has potent anti-proliferative and cell differentiation-inducing activities in addition to its role in calcium homeostasis. After the expression of various biological activities, 1␣,25(OH) 2 D 3 is further metabolized through the C-24 (3-6)/C-23 (7-10) oxidation pathways and the C-3 epimerization pathway (11-14). The C-24 oxidation pathway, initiated by C-24 hydroxylation, leads to the conversion of 1␣,25(OH) 2 D 3 into a side chain cleavage product, calcitroic acid (4, 5). The C-23 oxidation pathway, initiated by C-23 hydroxylation, leads to the formation of 1␣,25(OH) 2 D 3 -26,23-lactone (7-10). The newly discovered C-3 epimerization pathway leads to the conversion of the configuration of the hydroxyl group at C-3 of the A-ring and produces 3-epi-1␣,25(OH) 2 D 3 from 1␣,25(OH) 2 D 3 . In view of this modification at the A-ring, the C-3 epimerization pathway is quite different from side chain oxidation pathways.The C-3 epimerization of 1␣,25(OH) 2 D 3 was observed in human colon carcinoma-derived Caco-2 cells (11), bovine parathyroid cells (12), rat osteoblastic UMR 106 and Ros17/2.8 cells (13), and various cultured cell lines (14). From these studies, the C-3 epimerization pathway is assumed to be cell-selective. It was considered that the C-3 epimerization pathway is cell differentiation-related in Caco-2 cells, because 3-epi-1␣,25 (OH) 2 D 3 was only observed in confluent, quiescent Caco-2 cells, not proliferating Caco-2 cells (11). 3-Epi-1␣,25(OH) 2 D 3 was also isolated as a circulating metabolite of 1␣,25(OH) 2 D 3 in rats treated with pharmacological doses of 1␣,25(OH) 2 D 3 (15). In addition, synthetic analogs of 1␣,25(OH) 2 D 3 , e.g. 22-oxacalcitriol (16), 20-epi-1␣,25(OH) 2 D 3 (17), and 1␣,25(OH) 2 -16-ene-23-yne-D 3 (18), have been reported to be metabolized to their * This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan, a grant for Cooperative Research administered by the Japan Private School Promotion Foundation, and a grant-in-aid from the Ministry of Health and Welfare of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.§ § To whom correspondence should be addressed: Dept.